TY - JOUR
T1 - Use of recombinant proteins as a simple and robust normalization method for untargeted proteomics screening
T2 - exhaustive performance assessment
AU - Anjo, Sandra Isabel
AU - Simões, Isaura
AU - Castanheira, P.
AU - Grãos, Mário
AU - Manadas, B.
N1 - Funding Information:
This work was financed by the European Regional Development Fund (ERDF) through the COMPETE 2020 - Operational Programme for Competitiveness and Internationalisation and Portuguese national funds via FCT – Fundação para a Ciência e a Tecnologia , I.P., under projects: PTDC/NEU-NMC/0205/2012 , POCI-01-0145-FEDER-007440 (ref.; UID/NEU/04539/2013 ), POCI-01-0145-FEDER-016428 (ref.: SAICTPAC/0010/2015 ), POCI-01-0145-FEDER-016795 (ref.: PTDC/NEU-SCC/7051/2014 ), POCI-01-0145-FEDER-029311 (ref.: PTDC/BTM-TEC/29311/2017 ), POCI-01-0145-FEDER-30943 (ref.: PTDC/MEC-PSQ/30943/2017 ), and PTDC/MED-NEU/27946/2017 ; and by The National Mass Spectrometry Network (RNEM) under the contract LISBOA-01-0145-FEDER-402-022125 (ref.: ROTEIRO/0028/2013 ).
Publisher Copyright:
© 2019 Elsevier B.V.
Copyright:
Copyright 2019 Elsevier B.V., All rights reserved.
PY - 2019/12/1
Y1 - 2019/12/1
N2 - The label-free quantitative mass spectrometry methods, in particular, the SWATH-MS approach, have gained popularity and became a powerful technique for comparison of large datasets. In the present work, it is evaluated the use of recombinant proteins as internal standards for untargeted label-free methods. The proposed internal standard strategy reveals a similar intragroup normalization capacity when compared with the most common normalization methods, with the additional advantage of maintaining the overall proteome changes between groups (which is buffered with the use of other methods). Therefore, the proposed strategy is able to maintain a good performance even when large qualitative and quantitative differences in sample composition are observed, such as the ones induced by biological regulation (as observed in secretome and other biofluids’ analyses) or by enrichment approaches (such as immunopurifications). Moreover, this approach corresponds to a cost-effective and simple normalization method altrenative, therefore being an appealing strategy for large quantitative screening, as the analysis of clinical cohorts for biomarker discovery.
AB - The label-free quantitative mass spectrometry methods, in particular, the SWATH-MS approach, have gained popularity and became a powerful technique for comparison of large datasets. In the present work, it is evaluated the use of recombinant proteins as internal standards for untargeted label-free methods. The proposed internal standard strategy reveals a similar intragroup normalization capacity when compared with the most common normalization methods, with the additional advantage of maintaining the overall proteome changes between groups (which is buffered with the use of other methods). Therefore, the proposed strategy is able to maintain a good performance even when large qualitative and quantitative differences in sample composition are observed, such as the ones induced by biological regulation (as observed in secretome and other biofluids’ analyses) or by enrichment approaches (such as immunopurifications). Moreover, this approach corresponds to a cost-effective and simple normalization method altrenative, therefore being an appealing strategy for large quantitative screening, as the analysis of clinical cohorts for biomarker discovery.
KW - Biofluids
KW - Data normalization
KW - Internal standard
KW - Proteomics screening
KW - SWATH-MS
UR - http://www.scopus.com/inward/record.url?scp=85069659407&partnerID=8YFLogxK
U2 - 10.1016/j.talanta.2019.120163
DO - 10.1016/j.talanta.2019.120163
M3 - Article
C2 - 31450411
AN - SCOPUS:85069659407
SN - 0039-9140
VL - 205
JO - Talanta
JF - Talanta
M1 - 120163
ER -